Unfortunately, there are currently limited studies on B2M, and the precise mechanisms by which these alternative immune cells are activated and mediate immune responses in the setting of B2M deficiency warrant further investigation. The gene discussed is B2M; the disease is hyperinsulinemic hypoglycemia, familial, 4.